Use of genetically engineered bone-marrow stem cells to treat femoral defects: An experimental study

Journal of Bone and Joint Surgery

Volumn 88, Issue SUPPL. 3, 2006, Pages 167-172

  Cui, Quanjun ^a   Xiao, Zengming ^b   Li, Xudong ^b   Saleh, Khaled J ^b   Balian, Gary ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; BONE DEFECT; BONE RADIOGRAPHY; BONE REMODELING; CELL CLONE; CELL TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; DECOMPRESSION SURGERY; FEMUR; GENETIC ENGINEERING; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HISTOLOGY; KIDNEY CAPSULE; MORPHOMETRICS; MOUSE; MUSCLE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

EID: 33750685030     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.F.00891     Document Type: Conference Paper

References (69)

1. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006;88:1117-32.
2. Erratum in: J Bone Joint Surg Am. 2006;88:1602.
3. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, Urbaniak JR. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003;52:337-55.
4. Etienne G, Mont MA, Ragland PS. The diagnosis and treatment of nontraumatic osteonecrosis of the femoral head. Instr Course Lect. 2004;53:67-85.
5. Arlet J. Nontraumatic avascular necrosis of the femoral head. Past, present, and future. Clin Orthop Relat Res. 1992;277:12-21.
6. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459-74.
7. Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH. Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br. 1995;77:870-4.
8. Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res. 1996;324:169-78.
9. Mont MA, Jones LC, Pacheco I, Hungerford DS. Radiographic predictors of outcome of core decompression for hips with osteonecrosis stage III. Clin Orthop Relat Res. 1998;354:159-68.
10. Mont MA, Ragland PS, Etienne G. Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res. 2004;429:131-8.
11. Lieberman JR. Core decompression for osteonecrosis of the hip. Clin Orthop Relat Res. 2004;418:29-33.
12. Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY. Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am. 2005;87:2380-7.
13. Lavernia CJ, Sierra RJ. Core decompression in atraumatic osteonecrosis of the hip. J Arthroplasty. 2000;15:171-8.
14. Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res. 2004;429:139-45.
15. Mont MA, Einhorn TA, Sponseller PD, Hungerford DS. The trapdoor procedure using autogenous cortical and cancellous bone grafts for osteonecrosis of the femoral head. J Bone Joint Surg Br. 1998;80:56-62.
16. Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop Relat Res. 1998;355 Suppl:S314-35.
17. Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res. 2000;371:10-27.
18. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56:283-94.
19. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7:259-64.
20. Bauer TW, Smith ST. Bioactive materials in orthopaedic surgery: overview and regulatory considerations. Clin Orthop Relat Res. 2002;395:11-22.
21. Lieberman JR, Le LQ, Wu L, Finerman GA, Berk A, Witte ON, Stevenson S. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res. 1998;16:330-9.
22. Reddi AH, Cunningham NS. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res. 1993;8 Suppl 2:3499-502.
23. Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev. 1994;4:737-44.
24. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-9.
25. Urist MR, Kovacs S, Yates KA. Regeneration of an enchondroma defect under the influence of an implant of human bone morphogenetic protein. J Hand Surg [Am]. 1986;11:417-9.
26. Goldstein SA, Bonadio J. Potential role for direct gene transfer in the enhancement of fracture healing. Clin Orthop Relat Res. 1998;355 Suppl:S154-62.
27. Lieberman JR, Ghivizzani SC, Evans CH. Gene transfer approaches to the healing of bone and cartilage. Mol Ther. 2002;6:141-7.
28. Connolly JF. Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis. Clin Orthop Relat Res. 1998;355 Suppl:S257-66.
29. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res. 1991;266:259-70.
30. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res. 1998;355 Suppl:S247-56.
31. Bauer TW, Togawa D. Bone graft substitutes: towards a more perfect union. Orthopedics. 2003;26:925-6.
32. Cui Q, Xiao, ZM, Balian, G, Wang GJ. Use of a cloned osteoprogenitor cell in spinal fusion. In: Lewandrowski K-U, Tranto DJ, White AA, Wise DL, Yaszemski MJ, editors. Advances in spinal fusion: molecular science, biomechanics, and clinical management. New York: Marcel Dekker; 2004. p 93-102.
33. Cui Q, Ming Xiao Z, Balian G, Wang GJ. Comparison of lumbar spine fusion using mixed and cloned marrow cells. Spine. 2001;26:2305-10.
34. Cui Q, Wang GJ, Balian G. Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice. Connect Tissue Res. 2000;41:45-56.
35. Cui Q, Wang GJ, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am. 1997;79:1054-63.
36. Dahir GA, Cui Q, Anderson P, Simon C, Joyner C, Triffitt JT, Balian G. Pluripotential mesenchymal cells repopulate bone marrow and retain osteogenic properties. Clin Orthop Relat Res. 2000;379 Suppl:S134-45.
37. Diduch DR, Coe MR, Joyner C, Owen ME, Balian G. Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization. J Bone Joint Surg Am. 1993;75:92-105.
38. Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem. 1973;36:32-8.
39. Fisher LD, Van Belle G. Biostatistics: a methodology for the health sciences. New York: John Wiley; 1993.
40. Einhorn TA, Lee CA. Bone regeneration: new findings and potential clinical applications. J Am Acad Orthop Surg. 2001;9:157-65.
41. Lieberman JR. Orthopaedic gene therapy. Fracture healing and other nongenetic problems of bone. Clin Orthop Relat Res. 2000;379 Suppl:S156-8.
42. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 1998;355 Suppl:S7-21.
43. Fang TD, Salim A, Xia W, Nacamuli RP, Guccione S, Song HM, Carano RA, Filvaroff EH, Bednarski MD, Giaccia AJ, Longaker MT. Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res. 2005;20:1114-24.
44. Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM. The biology of bone grafting. J Am Acad Orthop Surg. 2005;13:77-86.
45. Lane JM, Tomin E, Bostrom MP. Biosynthetic bone grafting. Clin Orthop Relat Res. 1999;367 Suppl:S107-17.
46. Johnson EE, Urist MR, Finerman GA. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clin Orthop Relat Res. 1988;236:249-57.
47. Lane JM, Yasko AW, Tomin E, Cole BJ, Waller S, Browne M, Turek T, Gross J. Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop Relat Res. 1999;361:216-27.
48. Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br. 2005;87:896-902.
49. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;405:14-23.
50. Mont MA, Ragland PS, Biggins B, Friedlaender G, Patel T, Cook S, Etienne G, Shimmin A, Kildey R, Rueger DC, Einhorn TA. Use of bone morphogenetic proteins for musculoskeletal applications. An overview. J Bone Joint Surg Am. 2004;86 Suppl 2:41-55.
51. Gangji V, Hauzeur JP. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. J Bone Joint Surg Am. 2005;87 Suppl 1(Pt 1):106-12.
52. Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am. 2004;86:1153-60.
53. Gangji V, Toungouz M, Hauzeur JP. Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther. 2005;5:437-42.
54. Azer N, Cui Q, Chang IL, Whiteman TL, Hahn C, Wang GJ, Balian G. Growth factor delivery by a cloned multipotent cell from bone marrow stroma potentiated bone repair. In: Yaszemski MJ, Altobelli DE, Hasirci V, Lewandrowski K-U, Wise DL, Trantolo DJ, editors. Tissue engineering and novel delivery systems. 1st ed. New York: Marcel Dekker; 2003. p 463-74.
55. Geiger F, Bertram H, Berger I, Lorenz H, Wall O, Eckhardt C, Simank HG, Richter W. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res. 2005;20:2028-35.
56. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999;5:623-8.
57. Street J, Winter D, Wang JH, Wakai A, McGuinness A, Redmond HP. Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res. 2000;378:224-37.
58. Glowacki J. Angiogenesis in fracture repair. Clin Orthop Relat Res. 1998;355 Suppl:S82-9.
59. Stevenson S. Enhancement of fracture healing with autogenous and allogeneic bone grafts. Clin Orthop Relat Res. 1998;355 Suppl:S239-46.
60. Harada S, Rodan SB, Rodan GA. Expression and regulation of vascular endothelial growth factor in osteoblasts. Clin Orthop Relat Res. 1995;313:76-80.
61. Midy V, Plouet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun. 1994;199:380-6.
62. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002;110:751-9.
63. Niyibizi C, Baltzer A, Lattermann C, Oyama M, Whalen JD, Robbins PD, Evans CH. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop Relat Res. 1998;355 Suppl:S148-53.
64. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA. 2002;99:9656-61.
65. Matsuyama J, Ohnishi I, Kageyama T, Oshida H, Suwabe T, Nakamura K. Osteogenesis and angiogenesis in regenerating bone during transverse distraction: quantitative evaluation using a canine model. Clin Orthop Relat Res. 2005;433:243-50.
66. Cui Q, Wang GJ, Su CC, Balian G. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res. 1997;344:8-19.
67. Wang GJ, Cui Q, Balian G. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res. 2000;370:295-310.
68. Conzemius MG, Brown TD, Zhang Y, Robinson RA. A new animal model of femoral head osteonecrosis: one that progresses to human-like mechanical failure. J Orthop Res. 2002;20:303-9.
69. Atsumi T, Kuroki Y, Yamano K. A microangiographic study of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 1989;246:186-94.